Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity.
D000328:Adult; D002715:Chlormadinone Acetate / Q000009:adverse effects; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005223:Fats; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D006493:Heparin / Q000378:metabolism; D006801:Humans; D008055:Lipids / Q000097:blood*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008074:Lipoproteins / Q000097:blood*; D008656:Mestranol / Q000009:adverse effects; D010743:Phospholipids / Q000378:metabolism; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
D003276:Contraceptives, Oral; D005223:Fats; D005230:Fatty Acids, Nonesterified; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D014280:Triglycerides; D002715:Chlormadinone Acetate; D006493:Heparin; D002784:Cholesterol; D008656:Mestranol; D008071:Lipoprotein Lipase